HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED MALE BREAST-CANCER

被引：0
|
作者：
PANNUTI, F [1 ]
MARTONI, A [1 ]
BUSUTTI, L [1 ]
GRAMELLINI, M [1 ]
PIANA, E [1 ]
机构：
[1] S ORSOLA M MALPIGHI HOSP,DIV RADIOTHERAPY,I-40138 BOLOGNA,ITALY
来源：
CANCER TREATMENT REPORTS | 1982年 / 66卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1763 / 1765
页数：3
相关论文
共 50 条
  • [21] CHEMOTHERAPY WITH OR WITHOUT HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ESTROGEN-RECEPTOR-NEGATIVE ADVANCED BREAST-CANCER
    GUNDERSEN, S
    KVINNSLAND, S
    KLEPP, O
    LUND, E
    HANNISDAL, E
    HOST, H
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) : 390 - 394
  • [22] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [23] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER RESISTANT TO ENDOCRINE AND CYTOTOXIC THERAPY
    DELENA, M
    BRAMBILLA, C
    VALAGUSSA, P
    BONADONNA, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) : 175 - 180
  • [24] HIGH-DOSE VERSUS LOW-DOSE ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL
    GALLAGHER, CJ
    MCKINNA, JA
    CAIRNDUFF, F
    SMITH, IE
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 213 - 213
  • [25] HORMONE THERAPY IN ADVANCED BREAST-CANCER - COMPARISON BETWEEN HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MAP) AND TAMOXIFEN (TMX)
    PANNUTI, F
    MARTONI, A
    FRUET, F
    CRICCA, A
    CANCER TREATMENT REPORTS, 1979, 63 (07): : 1219 - 1219
  • [26] CYCLICAL USE OF TAMOXIFEN AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER
    GUNDERSEN, S
    KVINNSLAND, S
    LUNDGREN, S
    KLEPP, O
    LUND, E
    BORMER, O
    HOST, H
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 17 (01) : 45 - 50
  • [27] PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR THE TREATMENT OF METASTATIC BREAST-CANCER WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE
    BLOSSEY, HC
    WANDER, HE
    KOEBBERLING, J
    NAGEL, GA
    CANCER, 1984, 54 (06) : 1208 - 1215
  • [28] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER - CLINICAL AND PHARMACOKINETIC STUDY WITH A COMBINED ORAL AND INTRAMUSCULAR REGIMEN
    BECHER, R
    MILLER, AA
    HOFFKEN, K
    GERHOLD, U
    HIRCHE, H
    SCHMIDT, CG
    CANCER, 1989, 63 (10) : 1938 - 1943
  • [29] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN HEAVILY PRETREATED PATIENTS WITH METASTATIC BREAST-CANCER
    GOSS, PE
    ASHLEY, S
    POWLES, TJ
    COOMBES, RC
    CANCER TREATMENT REPORTS, 1986, 70 (06): : 777 - 779
  • [30] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE CAUSES ADRENAL SUPPRESSION IN PATIENTS WITH BREAST-CANCER
    VANVEELEN, H
    HOUWERZIJL, J
    RODING, TJ
    TJABBES, T
    VERMEER, RJI
    SLEIJFER, DT
    PRATT, JJ
    WILLEMSE, PHB
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (10): : 1035 - 1036
12345